Green Alpha Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Green Alpha Advisors, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $9.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$9.2M
| Company | Shares | Value |
|---|---|---|
| CRSPCRISPR Therapeutics AG | 57,022 | $2.7M |
| MRNAModerna, Inc. | 34,338 | $1.7M |
| CRBUCaribou Biosciences, Inc. | 373,650 | $710K |
| PRMEPrime Medicine, Inc. | 191,171 | $665K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 152,098 | $467K |
| ARRYARRAY BIOPHARMA INC | 56,059 | $405K |
| EDITEditas Medicine, Inc. | 160,142 | $396K |
| REGNREGENERON PHARMACEUTICALS, INC. | 336 | $260K |
| TWSTTwist Bioscience Corp | 5,303 | $252K |
| CSTLCastle Biosciences Inc. | 9,945 | $244K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 546 | $244K |
| GHGuardant Health Inc. | 2,570 | $237K |
| ARCTArcturus Therapeutics Holdings Inc. | 28,138 | $217K |
| SOPHSOPHiA GENETICS SA | 42,952 | $213K |
| NTLAIntellia Therapeutics, Inc. | 14,167 | $182K |
| INOINOVIO PHARMACEUTICALS, INC. | 65,580 | $114K |
| DNAGinkgo Bioworks Holdings Inc. | 13,776 | $84K |
| ABCLAbCellera Biologics Inc. | 22,944 | $80K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.